版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
体外诊断试剂工作校准品/产品校准品互换性(基质效应)Excel计算模板,,,,,,,,,
依据:《GB/T21415-2008/ISO17511:2003体外诊断医疗器械生物样品中量的测量校准品和控制物质赋值的计量学溯源性》及WS/T356-2011基质效应与互通性评估指南的方法,,,,,,,,,
,,,,,,,,,,
,,,,,,,,,,
"《GB/T21415-2008/ISO17511:2003体外诊断医疗器械生物样品中量的测量校准品和控制物质赋值的计量学溯源性》要求:
7.2:制造商应同时使用参考测量程序[4.2.2b)或d]和常规测量程序[4.2.2j]测量制造商工作校准品和一组相关的人体样品[4.2.2g],评估工作校准品的互换性。
如果参考测量程序的结果x和常规测量程序的结果y的数学关系,对人体样品和制造商工作校准品无明显差别,则可以证明校准品的互换性。
参考测量程序测量工作校准品的的结果x和常规测量程序测量工作校准品的结果y值如以及参考测量程序测量一组相关的人体样品的的结果x和常规测量程序测量一组相关的人体样品的结果y值如下:",,,,,,,,,
备注:图中校准品结果在95%置信限内,两种方法检测工作校准品的数学关系一致,工作校准品的互换性满足要求。,,,,,,,,,
上图引用数据计算如下:,,,,,,,,,
工作校准品的互换性(基质效应)计算,,,,,,,,,
用工作校准品给产品校准品赋值,再用试剂盒测工作校准品+人体相关样本,结果如下,,,,,,,,,
序号,自产试剂盒(多次测量xi),,,自产平均,参考试剂盒(多次测量yi),,,参考平均,备注
1,67.71,65.88,67.10,66.90,70.35,63.04,73.33,68.91,人体相关标本
2,159.74,170.92,172.84,167.83,147.60,154.63,154.31,152.18,人体相关标本
3,30.85,27.86,33.32,30.68,29.99,29.00,32.15,30.38,人体相关标本
4,68.84,69.39,70.01,69.41,66.84,65.74,69.05,67.21,人体相关标本
5,197.51,205.81,198.30,200.54,188.23,217.26,186.05,197.18,人体相关标本
6,51.35,50.63,54.89,52.29,50.99,48.63,47.96,49.19,人体相关标本
7,68.13,61.39,74.19,67.90,68.06,61.59,67.65,65.77,人体相关标本
8,189.50,204.66,189.88,194.68,186.85,180.59,180.97,182.80,人体相关标本
9,89.81,94.75,95.11,93.22,81.64,97.98,97.17,92.26,人体相关标本
10,196.87,211.24,205.73,204.61,179.94,190.77,191.95,187.55,人体相关标本
11,96.58,96.87,103.73,99.06,91.65,88.27,105.08,95.00,人体相关标本
12,178.09,191.62,180.94,183.55,177.73,195.72,195.54,189.66,人体相关标本
13,187.50,198.19,201.56,195.75,192.38,193.69,189.75,191.94,人体相关标本
14,114.85,113.36,106.35,111.52,125.07,124.50,125.30,124.96,人体相关标本
15,109.98,118.01,104.92,110.97,113.06,102.17,117.57,110.93,人体相关标本
16,97.98,107.29,100.72,102.00,102.49,91.32,93.67,95.83,人体相关标本
17,81.63,85.63,86.69,84.65,88.08,80.98,88.24,85.77,人体相关标本
18,150.98,141.02,143.43,145.14,163.21,155.21,154.30,157.57,人体相关标本
19,83.61,76.84,91.47,83.97,82.94,90.80,85.70,86.48,人体相关标本
20,126.66,121.97,136.03,128.22,138.31,127.42,121.85,129.19,人体相关标本
21,104.53,108.71,95.02,102.75,107.14,110.80,108.50,108.81,人体相关标本
22,115.33,121.90,109.10,115.44,124.90,125.13,103.80,117.94,人体相关标本
23,34.48,36.07,33.24,34.60,35.65,35.76,35.38,35.60,人体相关标本
24,145.12,134.38,146.14,141.88,143.52,158.62,145.41,149.18,人体相关标本
25,27.32,26.28,28.55,27.38,26.50,29.83,26.31,27.55,人体相关标本
26,125.98,138.07,137.32,133.79,133.54,118.67,119.05,123.75,人体相关标本
27,130.06,137.99,120.57,129.54,119.66,133.44,125.51,126.20,人体相关标本
28,168.79,156.13,162.71,162.54,170.31,163.39,172.84,168.85,人体相关标本
29,137.84,125.85,125.02,129.57,128.74,151.21,128.60,136.18,人体相关标本
30,103.92,93.63,96.13,97.89,103.19,107.45,101.11,103.92,人体相关标本
31,24.53,26.40,26.58,25.84,22.95,27.05,27.25,25.75,校准品水平1
32,36.00,38.56,41.28,38.61,39.92,39.96,40.12,40.00,校准品水平2
33,73.68,79.36,74.24,75.76,85.92,75.84,81.12,80.96,校准品水平3
34,131.16,127.32,122.28,126.92,112.08,125.40,127.56,121.68,校准品水平4
34,173.92,162.72,156.48,164.37,149.44,153.12,165.28,155.95,校准品水平4
35,212.00,204.20,203.20,206.47,200.60,206.80,219.40,208.93,校准品水平5
,,,,,,,,,,
校准品互换性回归曲线中间计算结果,序号,自产均值xi,(xi-x平均)^2,对照均值yi,y回归,95%置信下限,95%置信上限,样品,
,1,66.90,2373.0,68.91,68.3,51.1,85.5,人体相关样本1,
,2,167.83,2727.3,152.18,165.7,148.4,183.0,人体相关样本2,
,3,30.68,7213.7,30.38,33.4,15.6,51.1,人体相关样本3,
,4,69.41,2134.1,67.21,70.7,53.5,87.9,人体相关样本4,
,5,200.54,7213.1,197.18,197.2,179.5,215.0,人体相关样本5,
,6,52.29,4009.4,49.19,54.2,36.8,71.6,人体相关样本6,
,7,67.90,2275.9,65.77,69.3,52.0,86.5,人体相关样本7,
,8,194.68,6252.1,182.80,191.6,173.9,209.2,人体相关样本8,
,9,93.22,501.2,92.26,93.7,76.7,110.7,人体相关样本9,
,10,204.61,7921.6,187.55,201.2,183.3,219.0,人体相关样本10,
,11,99.06,273.9,95.00,99.3,82.3,116.3,人体相关样本11,
,12,183.55,4615.9,189.66,180.8,163.3,198.3,人体相关样本12,
,13,195.75,6422.4,191.94,192.6,174.9,210.3,人体相关样本13,
,14,111.52,16.7,124.96,111.3,94.4,128.3,人体相关样本14,
,15,110.97,21.5,110.93,110.8,93.8,127.8,人体相关样本15,
,16,102.00,185.3,95.83,102.2,85.2,119.2,人体相关样本16,
,17,84.65,958.5,85.77,85.4,68.3,102.5,人体相关样本17,
,18,145.14,872.2,157.57,143.8,126.7,160.9,人体相关样本18,
,19,83.97,1000.9,86.48,84.8,67.7,101.9,人体相关样本19,
,20,128.22,159.0,129.19,127.5,110.5,144.5,人体相关样本20,
,21,102.75,165.3,108.81,102.9,85.9,119.9,人体相关样本21,
,22,115.44,0.0,117.94,115.1,98.1,132.1,人体相关样本22,
,23,34.60,6563.1,35.60,37.1,19.5,54.8,人体相关样本23,
,24,141.88,690.1,149.18,140.6,123.6,157.7,人体相关样本24,
,25,27.38,7783.9,27.55,30.2,12.4,48.0,人体相关样本25,
,26,133.79,330.5,123.75,132.8,115.8,149.9,人体相关样本26,
,27,129.54,194.0,126.20,128.7,111.7,145.7,人体相关样本27,
,28,162.54,2202.7,168.85,160.6,143.3,177.8,人体相关样本28,
,29,129.57,194.9,136.18,128.8,111.7,145.8,人体相关样本29,
,30,97.89,313.9,103.92,98.2,81.2,115.2,人体相关样本30,
,31,25.84,8059.2,25.75,28.7,10.8,46.5,校准品水平1,
,32,38.61,5928.5,40.00,41.0,23.4,58.6,校准品水平2,
,33,75.76,1588.0,80.96,76.8,59.7,94.0,校准品水平3,
,34,126.92,127.9,121.68,126.2,109.2,143.2,校准品水平4,
,34,164.37,2377.9,155.95,162.3,145.1,179.6,校准品水平5,
,35,206.47,8255.0,208.93,202.9,185.1,220.8,校准品水平6,
,,,,,,,,,,
产品校准品的互换性计算,,,,,,,,,
"《GB/T21415-2008/ISO17511:2003体外诊断医疗器械生物样品中量的测量校准品和控制物质赋值的计量学溯源性》要求:
国标7.3:应同时使用参考程序和经校准的常规程序测量准备由常规测量程序测量的某类型的一组实际样品,将结果比较,以证实制造商产品校准品的互换性。
样品应是原始的、最好来自各个单一共同的、未添加任何物质的人体样品,它们的值应尽可能分布于被测量特定的测量区间的整个范围。
7.4:应对每个样品用参考和校准的常规程序进行重复测量。为达到计量学的溯源性,常规程序的结果应与参考程序的结果相关,如一定概率下线性回归的斜率为1,截距为0。
参考测量程序测量一组人体实际样品的的结果x和常规测量程序测量一组人体实际样品的结果y值如下:",,,,,,,,,
备注:图中校准品结果在95%置信限内,两种方法检测工作校准品的数学关系一致,工作校准品的互换性满足要求。,,,,,,,,,
序号,自产试剂盒(多次测量xi),,,自产平均,参考试剂盒(多次测量yi),,,参考平均,备注
1,160.66,159.21,162.59,160.82,165.96,147.81,155.68,156.48,人体实际标本
2,180.60,177.71,179.34,179.22,186.74,195.77,191.44,191.32,人体实际标本
3,186.84,200.48,198.61,195.31,181.98,202.16,187.59,190.58,人体实际标本
4,108.87,113.55,114.64,112.35,105.60,100.81,113.66,106.69,人体实际标本
5,130.76,134.81,117.95,127.84,130.50,133.51,132.46,132.16,人体实际标本
6,99.09,95.42,108.21,100.91,99.09,97.11,101.86,99.35,人体实际标本
7,152.31,152.31,148.65,151.09,140.43,141.65,158.86,146.98,人体实际标本
8,146.84,151.39,155.94,151.39,142.14,132.16,153.59,142.63,人体实际标本
9,134.46,123.30,133.52,130.43,137.28,126.12,144.54,135.98,人体实际标本
10,140.70,132.40,154.49,142.53,143.23,145.06,136.76,141.68,人体实际标本
11,80.33,79.04,77.12,78.83,72.38,76.39,80.49,76.42,人体实际标本
12,110.06,117.21,103.24,110.17,119.19,100.93,100.26,106.79,人体实际标本
13,130.06,118.09,130.32,126.16,131.75,134.87,128.76,131.79,人体实际标本
14,129.60,140.62,118.71,129.64,131.03,134.14,122.47,129.21,人体实际标本
15,77.64,72.59,80.36,76.86,74.22,78.57,84.94,79.24,人体实际标本
16,83.07,88.64,83.15,84.95,87.47,75.26,88.64,83.79,人体实际标本
17,38.53,40.19,41.27,40.00,37.61,37.95,40.84,38.80,人体实际标本
18,78.10,71.31,71.15,73.52,75.52,82.55,81.69,79.92,人体实际标本
19,162.28,172.83,157.90,164.34,150.43,160.17,159.03,156.54,人体实际标本
20,122.34,131.76,123.56,125.89,126.50,111.57,118.06,118.71,人体实际标本
21,133.21,143.73,132.28,136.41,120.95,143.60,122.02,128.86,人体实际标本
22,68.27,68.20,62.47,66.31,71.48,70.73,73.
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年水电站水资源综合利用合同范本3篇
- 2025年度个人房产买卖合同交房验收协议4篇
- 砖墙加固施工方案
- 建筑设计交付协议(2篇)
- 2025年度个人房产权属转移合同示范文本4篇
- 2025年行政事业单位合同管理制度规范与合同变更管理3篇
- 毕业回忆录模板
- 二零二五年度环保产业合作-环保设备让与担保合作协议4篇
- 2024年注册城乡规划师考试题库及参考答案(巩固)
- 违规网上行医自查报告(3篇)
- 2025-2030年中国草莓市场竞争格局及发展趋势分析报告
- 奕成玻璃基板先进封装中试线项目环评报告表
- 广西壮族自治区房屋建筑和市政基础设施全过程工程咨询服务招标文件范本(2020年版)修订版
- 2024新版有限空间作业安全大培训
- GB/T 44304-2024精细陶瓷室温断裂阻力试验方法压痕(IF)法
- 太阳能驱动的污水处理技术研究与应用
- 高三学生如何缓解心理压力讲义
- 陕西省公务员考试:《行测》2023年考试真题与参考答案
- 五年级上册口算练习400题及答案
- 高三数学寒假作业1
- 1例左舌鳞癌手术患者的围手术期护理体会
评论
0/150
提交评论